Your browser doesn't support javascript.
loading
Author Correction: The Molecular Tumor Board Portal supports clinical decisions and automated reporting for precision oncology.
Tamborero, David; Dienstmann, Rodrigo; Rachid, Maan Haj; Boekel, Jorrit; Lopez-Fernandez, Adria; Jonsson, Markus; Razzak, Ali; Braña, Irene; De Petris, Luigi; Yachnin, Jeffrey; Baird, Richard D; Loriot, Yohann; Massard, Christophe; Martin-Romano, Patricia; Opdam, Frans; Schlenk, Richard F; Vernieri, Claudio; Masucci, Michele; Villalobos, Xenia; Chavarria, Elena; Balmaña, Judith; Apolone, Giovanni; Caldas, Carlos; Bergh, Jonas; Ernberg, Ingemar; Fröhling, Stefan; Garralda, Elena; Karlsson, Claes; Tabernero, Josep; Voest, Emile; Rodon, Jordi; Lehtiö, Janne.
Afiliación
  • Tamborero D; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden. david.tamborero@ki.se.
  • Dienstmann R; Medical Oncology, Oncology Data Science, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Rachid MH; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Boekel J; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Lopez-Fernandez A; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Jonsson M; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Razzak A; Department of Oncology and Pathology, Karolinska Institutet, Science for Life Laboratory, Stockholm, Sweden.
  • Braña I; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • De Petris L; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Yachnin J; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Baird RD; Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Loriot Y; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Massard C; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Martin-Romano P; Département d'Innovation Thérapeutique et d'Essais Précoces, Gustave Roussy, Université Paris-Saclay, Villejuif, France.
  • Opdam F; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
  • Schlenk RF; NCT Trial Center, German Cancer Research Center, Heidelberg University Hospital, Heidelberg, Germany.
  • Vernieri C; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Masucci M; IFOM, FIRC Institute of Molecular Oncology, Milan, Italy.
  • Villalobos X; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Chavarria E; Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Apolone G; Hereditary Cancer Genetics Group, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Caldas C; Scientific Directorate, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Bergh J; Cancer Research UK Cambridge Centre, Cambridge, UK.
  • Ernberg I; Department of Oncology and Pathology, Karolinska Institutet, Theme Cancer, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Stockholm, Sweden.
  • Fröhling S; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Garralda E; National Center for Tumor Diseases Heidelberg, German Cancer Research Center, Heidelberg, Germany.
  • Karlsson C; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Tabernero J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
  • Voest E; Department of Hematology, Karolinska University Hospital, Stockholm, Sweden.
  • Rodon J; Medical Oncology Department, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
  • Lehtiö J; The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Nat Cancer ; 3(5): 649, 2022 May.
Article en En | MEDLINE | ID: mdl-35449310
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Nat Cancer Año: 2022 Tipo del documento: Article País de afiliación: Suecia